Global Aripiprazole Market, By Drug Class (Antipsychotics, Antimanic Agents), Application (Major Depressive Disorders, Schizophrenia, Bipolar Mania, Others), Demographic (Adult, Pediatric), Dosage Form (Tablets, Orally Disintegrating Tablets, Oral Solution, Injection), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Global Aripiprazole Market
Aripiprazole market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.60% in the above mentioned forecast period.
Aripiprazole is an antipsychotic drug used to treat schizophrenia in adults and children over the age of 13. Aripiprazole is used to treat bipolar I disorder (manic depression) in adults and children aged 10 and up, either alone or in combination with a mood stabilizer. It is used in the treatment of major depressive disorder in adults in conjunction with antidepressant drugs. Aripiprazole oral tablet comes in both a brand-name and generic form. Abilify, Aristada and Abilify Maintena are brand names.
The rise in the prevalence of depression across the world will act a major driver for the expansion of aripiprazole market. Furthermore, increasing geriatric population, rising healthcare expenditure and increase in the number of patients suffering from schizophrenia, and bipolar mania are the factors that will expand the aripiprazole market. Other factors including changing lifestyle and rising awareness will positively impact the market growth rate.
Moreover, the rise in the research and development activities and emerging new markets will provide beneficial opportunities for the aripiprazole market in the forecast period of 2022-2029.
However, high cost of the drug and side effects associated with aripiprazole such constipation, headache, nausea, vomiting, dizziness, nervousness, heartburn and others. All these factors hamper the market growth. Lack of awareness will further challenge the aripiprazole market in the forecast period mentioned above.
This aripiprazole market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the aripiprazole market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Aripiprazole Market Scope and Market Size
The aripiprazole market is segmented on the basis of drug class, application, demographic, dosage form, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug class, the aripiprazole market is segmented into antipsychotics, and antimanic agents.
- On the basis of application, the aripiprazole market is segmented into major depressive disorders, schizophrenia, bipolar mania, and others.
- On the basis of demographic, the aripiprazole market is segmented into adult, and pediatric.
- On the basis of dosage form, the aripiprazole market is segmented into tablets, orally disintegrating tablets, oral solution, and injection. Tablets are further sub-segmented into 2mg, 5mg, 10mg, 15mg, 20mg and 30mg. Orally disintegrating tablets are further sub-segmented into 10mg and 15mg. Oral solution is further sub-segmented into 1mg/ml.
- On the basis of end-users, the aripiprazole market is segmented into clinic, hospital and others.
- The aripiprazole market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Aripiprazole Market Country Level Analysis
Aripiprazole market is analyzed and market size information is provided by the country, drug class, application, demographic, dosage form, end-users and distribution channel as referenced above.
The countries covered in the aripiprazole market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the aripiprazole market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing research and development activities and growing government support in this region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Aripiprazole market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Aripiprazole Market Share Analysis
Aripiprazole market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to aripiprazole market research.
Some of the major players operating in the aripiprazole market are Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lannett, Otsuka America Pharmaceutical, Inc., Alembic Pharmaceuticals Limited, Amneal Pharmaceuticals LLC, Barr Pharmaceuticals, OrchidPharma Ltd., Apotex Inc., Accord Healthcare, ANGITA, Alkem Labs, Octavius Pharma Pvt. Ltd., Interquim, SA de CV., Polpharma, and Medinex, among others.
SKU-